A new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
Access Rights
info:eu-repo/semantics/closedAccess
DOI
Abstract
Description
Journal or Series
Bone Marrow Transplantation
WoS Q Value
Scopus Q Value
Volume
55
Issue
SUPPL 1
Citation
İlhan, O., Cengiz Seval, G., Civriz Bozdağ, S., Deveci, B., Pehlivan, M., Kaynar, L. ... Gülbaş, Z. (2020). A new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib. Bone Marrow Transplantation içinde (329-330. ss.).
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
info:eu-repo/semantics/closedAccess
